REGISTERED NUMBER: SC779950 (Scotland)

Unaudited Financial Statements

for the Year Ended 31 August 2025

for

KS Neuro Ltd

Page

Balance Sheet

1

FIXED ASSETS

49,934

31,480

CURRENT ASSETS

388,591

174,763

CREDITORS

Amounts falling due within one year

(71,169

)

(49,736

)

NET CURRENT ASSETS

317,422

125,027

TOTAL ASSETS LESS CURRENT LIABILITIES

367,356

156,507

CAPITAL AND RESERVES

367,356

156,507

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

KS Neuro Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address are as below:

Registered number:

SC779950

Registered office:

4 Ravelston House Road

Edinburgh

EH4 3LW

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 5 (2024 - 5 ) .

3.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At the year end, the company owed the director £836 (2024: £80).

4.	OTHER FINANCIAL COMMITMENTS

The company had no financial commitments, guarantees or contingencies in the year ended 31st August 2025 (2024: None)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 August 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 August 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 28 May 2026 and were signed on its behalf by:

P M Keston - Director